Cancer
ASCO Breakthrough 2024: Radiation Alone Works as Well as Chemoradiation for Low-Risk Nasopharyngeal Cancer
2024-08-08
New Research Highlights Potential for Surgery-Free Management of Esophageal Cancer at ASCO Breakthrough 2024
2024-08-08
ROR1 in Focus as a target for ADC-based treatments: Recent Developments and Industry Challenges – Part III
2024-08-07
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
Major Cancer Research Publications at the 2024 American Society of Clinical Oncology Annual Meeting
2024-05-28
LATEST
The Targeted Strike – ADCs and Bispecifics Delivering Precision Payloads in Modern Oncology
2026-04-15
Researchers Develop New Method to Detect Extraterrestrial Life by Analyzing Patterns Across Planetary Populations
2026-04-15
Early Patient Involvement in Drug Development Linked to Reduced Costs and Faster Timelines
2026-04-15
Policy, Pricing, and Power: Why Europe’s Biotech Future Depends on Openness, Not Overregulation
2026-04-14
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California





